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Nonalcoholic fatty liver disease (NAFLD) is regarded as the
most significant liver disease from the twenty-first century
in the Western world. Although its development is surely
driven by environmental factors, it is also regulated by genetic
background. NAFLD ranges over a wide spectrum, extending
from nonalcoholic fatty liver (NAFL) which is generally
benign, through to nonalcoholic steatohepatitis (NASH) to
liver cirrhosis, end-stage liver disease, and even hepatocellu-
lar carcinoma (HCC) despite the absence of significant alco-
hol consumption. The relationship of NAFLDwith metabolic
alterations such as type 2 diabetes is well described and re-
lated to insulin resistance, with NAFLD being recognized as
the hepatic manifestation of metabolic syndrome. However,
NAFLD may also coincide with endocrine diseases such
as polycystic ovary syndrome, hypothyroidism, growth hor-
mone deficiency, or hypercortisolism. It is therefore essen-
tial to remember, when discovering altered liver enzymes
or hepatic steatosis on radiological exams, that endocrine
diseases can cause NAFLD. In the latest years, obstructive
sleep apnea syndrome (OSAS) has been associated NAFLD.
Experimental evidence suggests that chronic intermittent
hypoxiamay perwhole trigger liver injury, inflammation, and
fibrogenesis, and, interestingly, OSAS is also believed to be
one of the elements promoting the evolution of NAFLD from
steatosis to nonalcoholic steatohepatitis (NASH) [1–4].
Z. Prokopowicz et al. are stressing the importance of the
early diagnosis of NONAL in obese children and NAFLD
predictive risk factors include increased waist circumference,
elevated waist-hip ratio and waist-to-height ratio, and ele-
vated total cholesterol, triglycerides, and fasting insulin as
well as elevated glucose and insulin concentration in the
OGTT and HOMA-IR index. NAFLD increases the risk of
potential cardiovascular complications expressed by diagno-
sis of metabolic syndrome. The best independent predictive
risk factor for diagnosing NAFLD in obese children is fasting
insulin > 18.9 uIU/ml.
Shidfar et al. in their study aimed to examine the effect
of virgin olive oil on alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) and the severity of steatosis
in the NAFLD patients undergoing a weight-loss diet. Defini-
tive conclusion is that the consumption of a low calorie diet
enriched with olive oil, along with slight weight reduction,
reinforces the desired effects of weight loss in improving the
levels of the hepatic enzymes.
Y. Zhai et al. in their present paper investigated the associ-
ation between NAFLD and sarcopenia in elderly patients and
concluded that NAFLD is not independently associated with
sarcopenia in older patients.
Miyata and Miyata studied the correlation between the
period from the first to each examination date and the mean
value of FIB4 index during the past year to each examination
date was analyzed. In their conclusion, they claimed that
correlation estimated was thought to be the time-dependent
change of the mean FIB4 index during the past one year and
in the present study the correlation was proved to be ex-
tremely strong. The time-dependent change of FIB4 index
and its increase-decrease rate per year could be approximately
speculated.
Our team (B. Filipovic´ et al.) has been involved for
a while in cognitive changes exploration among different
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gastroenterology patients. We hypothesized that NAFLD, as
a condition, affects the brain tissue and, subsequently, the
cognitive state. according to our results, patients withNAFLD
had a greater risk to suffer from the cognitive impairment and
depression: RR = 3.9; 95% CI 1.815–8.381; and RR = 1.65; 95%
CI 1.16–2.36; .Briefly, NAFLD significantly influenced the
cognitive deficit and tissue volume reduction and patients
suffering from NAFLD had about four times higher risk of
having a cognitive impairment.
T. Milovanovic et al. investigated whether platelet count
(PC), mean platelet volume (MPV), and platelet distribution
width (PDW) can predict the presence of liver fibrosis in this
group of patients. In their conclusion, patients with NAFLD
have significantly higher values of PCT, PDW, andMPVwhen
compared to the healthy controls. Further studies are needed
to establish their potential use for prediction of the degree of
liver steatosis and fibrosis in NAFLD patients.
V. Nguyen et al. have analyzed clinical, anthropometric,
and biochemical changes at six months and after consecutive
treatment with two and three serials of intragastric balloons
(IGB). They concluded that IGB therapy is an effective, alter-
native nonsurgical means for weight loss in the management
of obesity and NAFLD over the short term, with greatest out-
comes observed after six months. Improvements in insulin
resistance and hepatic transaminases correlated with weight
change.
Apparently, according to the papers published in this
special issue, NAFLD is a serious problem, which each author
from their own aspect tried to clarify. Regarding the fact that
NAFLD is rarely isolated and that it is correlated with obesity,
diabetes type 2, polycystic ovarian syndrome, obstructive
sleep apnea, and some cognitive deficits, its pathophysiology
and clinical development require more investigations. Sug-
gestions for the treatment by the implantation of the intra-
gastric balloon must be considered as one of the treating solu-
tions in the future.
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